Elucidating the neuropathophysiology of COVID-19 using quantum dot biomimetics of SARS-CoV-2
Elucidating the neuropathophysiology of COVID-19 using quantum dot biomimetics of SARS-CoV-2
复制标题
DOI:
10.1117/12.2609118
复制
发表时间:
2022-03
期刊:
影响因子:
--
通讯作者:
W. Chiang;J. Urban;Angela Litzburg;B. Nilsson;H. Gelbard;Todd D. Krauss
中科院分区:
文献类型:
--
作者:
W. Chiang;J. Urban;Angela Litzburg;B. Nilsson;H. Gelbard;Todd D. Krauss
Quantum dots were encapsulated in polymeric phospholipid micelles conjugated to multiple ligands of SARS-CoV-2 spike protein to form fluorescent biomimetic nanoparticles for SARS-CoV-2 (COVID-QDs). Phosphatidylethanolaminepolyethylene glycol (PE:PEG) was appended with bis(4-methylphenyl)sulfone to form PE:PEG:bis-sulfone and selfassembled into micelles around CdSe/CdS core/shell quantum dots via thin-film rehydration. The introduction of the bissulfone group the surface of the micelle-encapsulated quantum dots provides multiple sites for conjugation to his-tagged SARS-CoV-2 spike protein via a bisalkylation mechanism. Based on the eluted unconjugated fraction, we estimate that an average of seven spike proteins are conjugated per COVID-QD. We treated an in-vitro model system for the neurovascular unit (NVU) with these COVID-QD constructs to investigate the COVID-QDs, and by proxy SARS-CoV-2, may modulate the NVU leading to the COVID-19 associated neuropathophysiology.